Correspondingly, inhibiting the Notch1/Hes5 signaling pathway markedly reduced the enhanced chemotactic motility induced by SVEP1 downregulation in ICC cells (Fig. 6F, G). Here, HES5 is linked to intrahepatic cholangiocarcinoma.